Co-occurring Psychiatric Symptoms Are Associated with Increased Psychological, Social, and Medical Impairment in Opioid Dependent Pregnant Women

Overview

Journal Am J Addict

Specialty Psychiatry

Date 2010 Aug 19

PMID 20716304

Citations 36

Authors

Margaret M Benningfield

Amelia M Arria

Karol Kaltenbach

Sarah H Heil

Susan M Stine

Mara G Coyle

Gabriele Fischer

Hendree E Jones

Peter R Martin

Affiliations

Soon will be listed here.

Abstract

The interaction of psychiatric symptoms with drug dependence during pregnancy is not well understood. This study examines the relationship of psychiatric symptoms to severity of drug use and drug-related problems among participants in a clinical trial of pharmacologic treatment of opioid dependence during pregnancy (N = 174). A total of 64.6% reported additional psychiatric symptoms (48.6% mood symptoms, 40.0% anxiety symptoms, and 12.6% suicidal thinking). Women who endorsed co-occurring psychiatric symptoms showed more severe impairment on the Addiction Severity Index. Further investigation is warranted to understand the effect of psychiatric symptoms on long-term maternal and neonatal outcomes.

Citing Articles

Recruitment and retention strategies to promote research engagement among caregivers and their children: A scoping review.

Corr T, Jusufagic A, Basting J, Caldwell C, King S, Zgierska A J Clin Transl Sci. 2024; 8(1):e194.

PMID: 39655035 PMC: 11626585. DOI: 10.1017/cts.2024.624.

Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome.

Coyle M, Ounpraseuth S, Lester B, Dansereau L, Hu Z, Laptook A J Perinatol. 2024; .

PMID: 39406940 DOI: 10.1038/s41372-024-02144-6.

A Randomized Trial Evaluating Acceptance and Commitment Therapy and Smart Phone Care Management Application to Augment Buprenorphine Therapy for Opioid Use and Chronic Pain.

Gallo L, Bhambhani Y, Lu T, Holzman S, Bao Y, Musicaro R Subst Use Addctn J. 2024; 46(1):166-174.

PMID: 39171416 PMC: 11652247. DOI: 10.1177/29767342241265178.

Guyon-Harris K, Krans E, Gill A, Karnosh C, Shaw D Infant Ment Health J. 2024; .

PMID: 39118311 PMC: 11806078. DOI: 10.1002/imhj.22132.

Cost of Care for Newborns With Neonatal Abstinence Syndrome in a State Medicaid Program.

Jenkins C, Hudnall M, Hanson C, Lewis D, Parton J JAMA Netw Open. 2024; 7(2):e240295.

PMID: 38407906 PMC: 10897737. DOI: 10.1001/jamanetworkopen.2024.0295.

References

Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57. View

Regier D, Farmer M, Rae D, Locke B, Keith S, Judd L . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264(19):2511-8. View

Martin P, Arria A, Fischer G, Kaltenbach K, Heil S, Stine S . Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict. 2009; 18(2):148-56. PMC: 2777700. DOI: 10.1080/10550490902772975. View

Simmons L, Havens J, Whiting J, Holz J, Bada H . Illicit drug use among women with children in the United States: 2002-2003. Ann Epidemiol. 2009; 19(3):187-93. PMC: 2680130. DOI: 10.1016/j.annepidem.2008.12.007. View

Jarvis M, Schnoll S . Methadone use during pregnancy. NIDA Res Monogr. 1995; 149:58-77. View

Bennett H, Einarson A, Taddio A, Koren G, Einarson T . Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004; 103(4):698-709. DOI: 10.1097/01.AOG.0000116689.75396.5f. View

Kidorf M, Disney E, King V, Neufeld K, Beilenson P, Brooner R . Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend. 2004; 74(2):115-22. DOI: 10.1016/j.drugalcdep.2003.11.014. View

Gentile S . The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf. 2005; 28(2):137-52. DOI: 10.2165/00002018-200528020-00005. View

Tuten M, Heil S, OGrady K, Fitzsimons H, Chisolm M, Jones H . The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse. 2010; 35(5):358-63. PMC: 3057901. DOI: 10.1080/00952990903108231. View

10.

Hides L, Lubman D, Devlin H, Cotton S, Aitken C, Gibbie T . Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Aust N Z J Psychiatry. 2007; 41(2):166-8. DOI: 10.1080/00048670601109949. View

11.

Newman L, Stevenson C, Bergman L, Boyce P . Borderline personality disorder, mother-infant interaction and parenting perceptions: preliminary findings. Aust N Z J Psychiatry. 2007; 41(7):598-605. DOI: 10.1080/00048670701392833. View

12.

Spitzer R, Williams J, GIBBON M, First M . The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992; 49(8):624-9. DOI: 10.1001/archpsyc.1992.01820080032005. View

13.

Mills K, Teesson M, Ross J, Peters L . Trauma, PTSD, and substance use disorders: findings from the Australian National Survey of Mental Health and Well-Being. Am J Psychiatry. 2006; 163(4):652-8. DOI: 10.1176/ajp.2006.163.4.652. View

14.

Lyons-Ruth K . CONTRIBUTIONS OF THE MOTHER-INFANT RELATIONSHIP TO DISSOCIATIVE, BORDERLINE, AND CONDUCT SYMPTOMS IN YOUNG ADULTHOOD. Infant Ment Health J. 2009; 29(3):203-218. PMC: 2613366. DOI: 10.1002/imhj.20173. View

15.

Jones H, Johnson R, Jasinski D, OGrady K, Chisholm C, Choo R . Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005; 79(1):1-10. DOI: 10.1016/j.drugalcdep.2004.11.013. View

16.

Cohen L, Altshuler L, Harlow B, Nonacs R, Newport D, Viguera A . Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006; 295(5):499-507. DOI: 10.1001/jama.295.5.499. View

17.

Kessler R, McGonagle K, Zhao S, Nelson C, Hughes M, Eshleman S . Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51(1):8-19. DOI: 10.1001/archpsyc.1994.03950010008002. View

18.

Kakko J, Heilig M, Sarman I . Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend. 2008; 96(1-2):69-78. DOI: 10.1016/j.drugalcdep.2008.01.025. View

19.

Suri R, Altshuler L, Hellemann G, Burt V, Aquino A, Mintz J . Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007; 164(8):1206-13. DOI: 10.1176/appi.ajp.2007.06071172. View

20.

Grant B, Stinson F, Dawson D, Chou S, Ruan W, Pickering R . Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61(4):361-8. DOI: 10.1001/archpsyc.61.4.361. View